BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38141155)

  • 1. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
    Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
    J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
    Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
    Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring.
    Pepe J; Cipriani C; Curione M; Biamonte F; Colangelo L; Danese V; Cecchetti V; Sonato C; Ferrone F; Cilli M; Minisola S
    Eur J Endocrinol; 2018 Aug; 179(2):117-124. PubMed ID: 29875287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias in primary hyperparathyroidism evaluated by exercise test.
    Pepe J; Curione M; Morelli S; Colotto M; Varrenti M; Castro C; D'Angelo A; Cipriani C; Piemonte S; Romagnoli E; Minisola S
    Eur J Clin Invest; 2013 Feb; 43(2):208-14. PubMed ID: 23278426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
    BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRIMARY HYPERPARATHYROIDISM, WITH A FOCUS ON MANAGEMENT OF THE NORMOCALCEMIC FORM: TO TREAT OR NOT TO TREAT?
    Šiprová H; Fryšák Z; Souček M
    Endocr Pract; 2016 Mar; 22(3):294-301. PubMed ID: 26523628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?
    Kiriakopoulos A; Petralias A; Linos D
    World J Surg; 2018 Apr; 42(4):992-997. PubMed ID: 29392434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR; Sapag Durán A; Zanchetta MB
    Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-hour outpatient ECG as a screening method in patients with primary hyperparathyroidism.
    Dokupilova A; Payer J
    Bratisl Lek Listy; 2016; 117(9):495-500. PubMed ID: 27677191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
    Yener Ozturk F; Erol S; Canat MM; Karatas S; Kuzu I; Dogan Cakir S; Altuntas Y
    Endocr J; 2016; 63(2):111-8. PubMed ID: 26581584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normocalcemic and Normohormonal Primary Hyperparathyroidism: Laboratory Values and End-Organ Effects.
    Hollowoa BR; Spencer HJ; Stack BC
    Otolaryngol Head Neck Surg; 2021 Sep; 165(3):387-397. PubMed ID: 33461421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
    Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
    Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism.
    Tuna MM; Çalışkan M; Ünal M; Demirci T; Doğan BA; Küçükler K; Özbek M; Berker D; Delibaşı T; Güler S
    J Bone Miner Metab; 2016 May; 34(3):331-5. PubMed ID: 26056016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
    Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
    Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?
    Yu Q; Liu K; Ma D; Xie C; Wu Y; Dai W; Jiang H
    Biomed Res Int; 2019; 2019():2150159. PubMed ID: 31355250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test.
    Pepe J; Curione M; Morelli S; Varrenti M; Cammarota C; Cilli M; Piemonte S; Cipriani C; Savoriti C; Raimo O; De Lucia F; Colangelo L; Clementelli C; Romagnoli E; Minisola S
    Eur J Endocrinol; 2013 Aug; 169(2):255-61. PubMed ID: 23744591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
    Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
    Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.